Case File
efta-efta00905603DOJ Data Set 9OtherFrom: "Dubin, Glenn"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00905603
Pages
1
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Dubin, Glenn"
To: "'Jeffrey Epstein"' <[email protected]>
Subject: FW: FYI
Date: Fri, 25 Feb 2011 18:51:30 +0000
Inline-Images: image001.gif
From: Venkataraman, Subu
Sent: Friday, February 25, 2011 9:38 AM
To: Dubin, Glenn
Subject: FYI
SEC exonerates hedge fund manager Daniel Zwirn after completing
investigation of hedge fund
Thursday, February 24, 2011 Share
Print Email Track Keywords
Opalesque Industry Update - According to documents obtained by Opalesque, the New York office of the Securities and Exchange
Commission yesterday decided not to recommend any enforcement action against Daniel Zwirn (Dan Zwirn) after completing their
investigation of D.B. Zwim & Co, L.P.
According to an 2008 FT article (Source), the SEC started to investigate the valuation process of the hedge funds assets shortly after it
informed investors that it would shut down in the face of massive redemptions.
The issue was brought up by the firm itself, saying that a manager who had left in 2005 had failed to "follow a systematic pricing
methodology" for a portfolio of hard-to-trade assets, which could have resulted in a marginal overvaluing. Besides, the SEC also
examined internal fund transfers and billing of expenses to investors.
This e-mail message is intended only for the named recipient(s) above. It may contain confidential information. If you are not the intended recipient
you are hereby notified that any dissemination, distribution or copying of this e-mail and any attachment(s) is strictly prohibited. If you have received
this e-mail in error, please immediately notify the sender by replying to this e-mail and delete the message and any attachment(s) from your system.
Thank you.
EFTA00905603
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.